Overview
Oblique facial cleft, also known as meloschisis or lateral facial cleft, is a rare congenital craniofacial malformation characterized by a cleft that extends from the upper lip toward the eye (orbit) along an oblique trajectory across the face. These clefts follow specific anatomical pathways classified by the Tessier numbering system (typically Tessier clefts 3, 4, and 5), which describes the location of the cleft relative to facial landmarks. The condition results from failure of fusion of the embryonic facial processes during early fetal development, typically between the 4th and 8th weeks of gestation. Oblique facial clefts can involve soft tissue alone or extend through underlying bone, affecting the maxilla, orbital floor, and surrounding structures. Clinical features vary depending on the severity and exact location of the cleft but commonly include a visible groove or fissure extending from the lip or nose toward the lower eyelid or medial orbit, coloboma (notching) of the lower eyelid or alar region of the nose, nasolacrimal duct obstruction, and orbital dystopia. The cleft may be unilateral or bilateral and can be associated with other craniofacial anomalies. Affected individuals may experience difficulties with feeding, speech, vision, and breathing depending on the extent of the malformation. The condition can also have significant psychosocial impact due to facial disfigurement. Treatment is primarily surgical and typically requires a multidisciplinary approach involving craniofacial surgeons, ophthalmologists, otolaryngologists, speech therapists, and orthodontists. Surgical repair is usually staged over multiple procedures during childhood, aiming to reconstruct soft tissue and bony defects, restore facial symmetry, and optimize functional outcomes including feeding, speech, and eye protection. The etiology is generally considered multifactorial, though some cases may be associated with amniotic band syndrome or chromosomal abnormalities. Early diagnosis, often possible prenatally via ultrasound, allows for coordinated care planning.
Also known as:
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Oblique facial cleft.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Oblique facial cleft at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Oblique facial cleft.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Oblique facial cleft.
Community
No community posts yet. Be the first to share your experience with Oblique facial cleft.
Start the conversation →Latest news about Oblique facial cleft
No recent news articles for Oblique facial cleft.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Oblique facial cleft
What is Oblique facial cleft?
Oblique facial cleft, also known as meloschisis or lateral facial cleft, is a rare congenital craniofacial malformation characterized by a cleft that extends from the upper lip toward the eye (orbit) along an oblique trajectory across the face. These clefts follow specific anatomical pathways classified by the Tessier numbering system (typically Tessier clefts 3, 4, and 5), which describes the location of the cleft relative to facial landmarks. The condition results from failure of fusion of the embryonic facial processes during early fetal development, typically between the 4th and 8th weeks
How is Oblique facial cleft inherited?
Oblique facial cleft follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Oblique facial cleft typically begin?
Typical onset of Oblique facial cleft is neonatal. Age of onset can vary across affected individuals.